Form 8-K - Current report:
SEC Accession No. 0001144204-15-035521
Filing Date
2015-06-04
Accepted
2015-06-04 16:08:35
Documents
3
Period of Report
2015-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v412487_8-k.htm 8-K 23040
2 EXHIBIT 99.1 v412487_ex99-1.htm EX-99.1 13812
4 GRAPHIC tlogoex.jpg GRAPHIC 30998
  Complete submission text file 0001144204-15-035521.txt   81069
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 15913130
SIC: 2835 In Vitro & In Vivo Diagnostic Substances